VIBRANT: VIB4920 for Active Lupus Nephritis

(

VIBRANT

)

ITN Protocol #:

ITN091AI

Branded Name:

VIBRANT

ClinicalTrials.Gov ID:

NCT05201469

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Enrollment

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Study Personnel:

Protocol Chair

Maria Dall’Era, MD maria.dallera@ucsf.edu

Work:

415-476-0783

Protocol Chair

Betty Diamond, MD bdiamond@nshs.edu

Work:

516-562-3830

Protocol Chair

David Wofsy, MD wofsyd@medsch.ucsf.edu

Work:

415-750-2104

Protocol Chair

Patti Tosta ptosta@immunetolerance.org

Work:

415-353-4421

Protocol Chair

Kristin Ryker kryker@immunetolerance.org

Work:

415-353-4405

Protocol Chair

Laura Cooney, PhD lcooney@immunetolerance.org

Work:

734-274-1149

Protocol Chair

Dawn Smilek, MD PhD dsmilek@immunetolerance.org

Work:

415-353-4308

Protocol Chair

Wendy Gao gaowe@mail.nih.gov

Work:

240-627-3471

Protocol Chair

Ling Li, PhD lil16@niaid.nih.gov

Work:

240-627-3765